3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Treatment of End-stage Kidney Failure without Renal Replacement Therapy.

      1 , 2 , 3 , 4
      Seminars in dialysis
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          For the majority of patients with end-stage kidney failure (ESKF) replacement of excretory renal function by dialysis or transplantation (RRT) can extend life and alleviate symptoms. Historically, the availability of RRT has been insufficient and this remains the case for much of the world. However, RRT is now widely available in healthcare systems of higher income countries. Increasing numbers of elderly patients are developing ESKF. RRT in this population is largely by dialysis, comorbidity is high and life expectancy short. Evidence of effectiveness coupled with the burden of treatment among these individuals has raised concerns that health services in high-income countries may have moved from an era of unmet need into one of potential over-treatment. Alongside the requirement to make treatment more patient-centered, this has driven the development of comprehensive conservative care as an alternative approach for older comorbid individuals with ESKF, with the potential for acceptable symptom control and reduced treatment burden. This paper provides a largely UK-perspective on treating ESKF without RRT. Emphasis is on the need for high-quality evidence to inform treatment decisions. Complexities of defining, delivering and improving treatment of ESKF without dialysis care are explored. Quantitative and qualitative evidence are summarized and the relationship with palliative and terminal care examined. A framework is suggested for classifying management of ESKF and recommendations made to improve delivery of nondialysis care in the future. For patients with a poor prognosis, such treatment may not result in significantly different survival or quality of life when compared with dialysis. There is a key need to generate the best possible evidence of person-centered health outcomes associated with the various treatment options for ESKF and to present this to patients in a balanced, personalized way that allows them to make the treatment decision most appropriate for them.

          Related collections

          Author and article information

          Journal
          Semin Dial
          Seminars in dialysis
          Wiley
          1525-139X
          0894-0959
          November 2016
          : 29
          : 6
          Affiliations
          [1 ] Department of Renal Medicine, North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom.
          [2 ] Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
          [3 ] UK Renal Registry, Learning and Research, Southmead Hospital, Bristol and School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
          [4 ] Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton and the University Hospital Southampton NHS Trust, Southampton, United Kingdom. pjr@soton.ac.uk.
          Article
          10.1111/sdi.12535
          27559004
          67abeb50-ce41-4b49-af23-e56e74c4d833
          History

          Comments

          Comment on this article